Screener
Eli Lilly LLY Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $7.1B+25.3% | $7.4B+168% | $6.64B+50.5% | $5.58B+475% | $5.66B+90.8% | ||
| $534M+11.7% | $509M+9.9% | $585.7M+20.7% | $470.3M+0.7% | $478M+15.3% | ||
| $201M+8.6% | $161M+4.5% | $136.1M-4.4% | $150.9M+13.3% | $185M-12.4% | ||
| $10.69B+246% | $5.33B+220% | $3.22B+30.3% | $8.84B+138% | $3.09B+111% | ||
| $2.93B+72.8% | $2.33B+54.0% | $2.55B+70.2% | $2.09B+54.5% | $1.7B+38.6% | ||
| $8.75B— | $1.06B— | $111.6M+37,100% | $549.4M— | $0— | ||
| -$15.4B-739% | -$3.92B-16.8% | -$2.8B-45.9% | -$2.98B+25.5% | -$1.83B+16.6% | ||
| $1.55B+14.8% | $1.55B+15.0% | $1.35B+15.2% | $1.35B+15.0% | $1.35B+14.9% | ||
| $1.6B+131% | $2.36B+96.3% | $1.51B-26.6% | $708.3M+58.8% | $692M— | ||
| $8.94B— | $0-100% | —— | $6.71B+35.1% | —— | ||
| $873M+12.2% | $750M— | $0-100% | $100K-99.9% | $778M+369% | ||
| $8.43B+777% | -$3.47B-351% | -$2.88B— | $530.8M+151% | -$1.25B-180% | ||
| $3.67B+1,196% | -$1.99B-1,035% | —— | $6.42B+4,312% | $283M-62.9% | ||
| $7.76B+458% | $3.01B+1,828% | $677.9M-30.7% | $6.75B+186% | $1.39B+476% |
FAQ
- How much cash does Eli Lilly generate?
- Eli Lilly (LLY) generated $28.1B in operating cash flow over the trailing twelve months.
- What is Eli Lilly's free cash flow?
- After $9.9B of capital expenditures, Eli Lilly's free cash flow was $18.2B over the trailing twelve months, up 272.4% year over year.
- Where does Eli Lilly's cash flow data come from?
- Every line is extracted from Eli Lilly's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
